We are proud to announce the opening of our new office in Amsterdam.
Our new offices are located next to the future location of the European Medicines Agency (EMA), at the World Trade Center (address Zuidplein 36 Amsterdam 1077 XV).
“We are delighted to announce the opening of our new Asphalion office in Amsterdam within walking distance from the EMA”, said Núria Romero, Manager Director at Asphalion. ”The location facilitates our interactions with EMA. From having a preparation meeting with our client for a Scientific Advice with EMA or a pre-submission meeting for the Centralised Procedure. Our new office can also accommodate the various meetings of Industry working groups, in which our employees participate, to help shape the future of Regulatory Affairs in Europe.
To celebrate the opening of our office in Amsterdam, we are planning various activities.
On 10th – 11th October, we are planning an event in the Netherland in which our experts and partners will discuss the European and US regulatory pathways and framework.
For now… Save the date and stay tuned! More details about the program and location will follow soon.
From 4 March 2019, the official address of the Agency will be that of its permanent building in Amsterdam Zuidas. However, EMA will not physically occupy its permanent building until the latter part of 2019. From 4th to 8th March, the Agency will operate remotely. From 11 to 15 March, EMA staff will gradually move into a temporary building in Amsterdam, called the Spark building.
As of 11 March 2019, all EMA face-to-face meetings will take place at the Spark building until EMA moves into its permanent building.
The address below should be used for attending EMA meetings:
European Medicines Agency
1043 DP Amsterdam